Genovate Biotechnology Co., Ltd. (TPEX:4130)
Taiwan · Delayed Price · Currency is TWD 26.70
0.00 (-0.37%)
Jul 21, 2026, 2:31 PM CST
Genovate Biotechnology Market Cap
Genovate Biotechnology has a market cap or net worth of 3.65 billion as of July 29, 2026. Its market cap has increased by 70.97% in one year.
Market Cap
3.65B
Enterprise Value
2.54B
Revenue
471.48M
Ranking
n/a
PE Ratio
n/a
Stock Price
26.70
ChartMarket Cap Chart
Since November 3, 2008, Genovate Biotechnology's market cap has increased from 664.80M to 3.65B, an increase of 449.22%. That is a compound annual growth rate of 10.09%.
| Date | Market Cap | % Change |
|---|---|---|
| Jul 21, 2026 | 3.65B | 15.88% |
| Dec 31, 2025 | 3.15B | 35.56% |
| Dec 31, 2024 | 2.32B | -20.11% |
| Dec 29, 2023 | 2.91B | -17.02% |
| Dec 30, 2022 | 3.51B | 31.05% |
| Dec 30, 2021 | 2.68B | -15.11% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Sinew Pharma | 4.34B |
| Formosa Pharmaceuticals | 3.67B |
| Senhwa Biosciences | 3.63B |
| OBI Pharma | 3.57B |
| Sagittarius Life Science | 3.36B |
| SYN-TECH Chem. & Pharm. | 3.22B |
| Apex Biotechnology | 3.22B |
| Shine-On BioMedical | 3.14B |